Bill

Bill > A5341


NJ A5341

NJ A5341
Establishes three-year Medicaid demonstration project to pay for certain drugs according to outcome-based system.


summary

Introduced
05/16/2019
In Committee
05/16/2019
Crossed Over
Passed
Dead
01/08/2020

Introduced Session

2018-2019 Regular Session

Bill Summary

This bill establishes a three-year Medicaid demonstration project to pay for certain drugs according to outcome-based system. Under the bill, the Department of Human Services will establish a three-year demonstration project to employ outcome-based payment systems for a limited number of prescription drugs covered under the program. The department will enter into purchasing or rebate agreements with the manufacturers of at least three different prescription drugs, which will provide that the total reimbursement paid by the State for such drugs will be based in some part on observed outcomes of the drug's use in patients. The drugs selected for the demonstration program will have specific therapeutic purposes with outcomes that are readily measurable with existing data systems, and will be among the highest-cost drugs in the New Jersey Medicaid program in aggregate spending. The department and the manufacturer of each drug selected for the program must agree to specific performance targets, methods of monitoring performance, and other relevant factors in the design of the demonstration program. The department will require that Medicaid managed care organizations participate in the demonstration program, and will specify the obligations of the managed care organizations under the demonstration program in the contract between the department and the managed care organizations. After the expiration of the three-year demonstration project, the Commissioner of Human Services will report to the Governor and Legislature on the results of the demonstration project, along with the commissioner's recommendations to expand, revise, or discontinue the demonstration project. The report shall include specific performance test results, aggregated and de-identified as necessary to protect patients' identities and health information protected by State and federal law.

AI Summary

This bill establishes a three-year Medicaid demonstration project to pay for certain drugs according to an outcome-based system. Under the bill, the Department of Human Services will enter into agreements with manufacturers of at least three high-cost Medicaid drugs to provide reimbursement based in part on the observed outcomes of the drugs' use in patients. The department will select drugs with measurable therapeutic outcomes and require Medicaid managed care organizations to participate in the demonstration program. After the three-year project, the Commissioner of Human Services will report on the results and provide recommendations on whether to expand, revise, or discontinue the demonstration.

Committee Categories

Health and Social Services

Sponsors (1)

Last Action

Introduced, Referred to Assembly Health and Senior Services Committee (on 05/16/2019)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...